Literature DB >> 16930851

Leptin controls adiponectin production via the hypothalamus.

P Huypens1.   

Abstract

Adipocyte generated endocrine signals, including leptin and adiponectin, control systemic insulin sensitivity as part of a broader control mechanism in energy balance. Leptin and adiponectin are inversely regulated in vivo, but not in vitro, suggesting that the inverse relationship is mediated via indirect mechanisms. The cytokine TNF-alpha has been proposed as a putative candidate in the reciprocal regulation of adiponectin and leptin. However, several recent findings, including the observation that adiponectin production is paradoxically increased in mouse models with selective hypothalamic leptin resistance, indicate that part of the inverse relationship between leptin and adiponectin is mediated via a neural interface. Therefore, we propose that adiponectin production is, at least in part, controlled by the hypothalamic actions of leptin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16930851     DOI: 10.1016/j.mehy.2006.06.031

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  3 in total

1.  Increased insulin sensitivity and reduced micro and macro vascular disease induced by 2-deoxy-D-glucose during metabolic syndrome in obese JCR: LA-cp rats.

Authors:  J C Russell; S D Proctor
Journal:  Br J Pharmacol       Date:  2007-03-20       Impact factor: 8.739

2.  Plasma adiponectin concentration is associated with the average accelerometer daily steps counts in healthy elderly females.

Authors:  Jaak Jürimäe; Tatjana Kums; Toivo Jürimäe
Journal:  Eur J Appl Physiol       Date:  2010-03-13       Impact factor: 3.078

3.  The arcuate nucleus and neuropeptide Y contribute to the antitumorigenic effect of calorie restriction.

Authors:  Robin K Minor; Miguel López; Caitlin M Younts; Bruce Jones; Kevin J Pearson; Robert Michael Anson; Carlos Diéguez; Rafael de Cabo
Journal:  Aging Cell       Date:  2011-04-05       Impact factor: 9.304

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.